These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17526542

  • 21. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 22. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
    Yorioka N, Kiribayashi K, Naito T, Ogata S, Yokoyama Y, Kyuden Y, Ogawa T, Wada K, Hayashi K, Hirabayashi A.
    J Nephrol; 2008 Feb; 21(2):213-20. PubMed ID: 18446716
    [Abstract] [Full Text] [Related]

  • 23. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Feb; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 24. Progression of renal failure in patients with compromised renal function is not always present: evaluation of underlying disease.
    Rottey S, Vanholder R, De Schoenmakere G, Lameire N.
    Clin Nephrol; 2000 Jul; 54(1):1-10. PubMed ID: 10939750
    [Abstract] [Full Text] [Related]

  • 25. Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database.
    Novak TE, Mathews R, Martz K, Neu A.
    J Urol; 2009 Oct; 182(4 Suppl):1678-81. PubMed ID: 19692051
    [Abstract] [Full Text] [Related]

  • 26. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [Abstract] [Full Text] [Related]

  • 27. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 28. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Apr; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 29. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 30. Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.
    Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, de Zeeuw D, Remuzzi G, Kamper AL, Levey AS.
    J Am Soc Nephrol; 2007 Jun; 18(6):1959-65. PubMed ID: 17475813
    [Abstract] [Full Text] [Related]

  • 31. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jun; 30(4):363-71. PubMed ID: 18569908
    [Abstract] [Full Text] [Related]

  • 32. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Jun; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 33. [Suppressive effect of angiotensin converting enzyme inhibitor (ACEI) on the progression of renal insufficiency: a propensity score analysis].
    Hirabayashi A, Ogawa T, Urashima M, Sone M, Nihei H.
    Nihon Jinzo Gakkai Shi; 2004 Jan; 46(1):35-42. PubMed ID: 15007909
    [Abstract] [Full Text] [Related]

  • 34. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 35. Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys.
    Neild GH, Thomson G, Nitsch D, Woolfson RG, Connolly JO, Woodhouse CR.
    BMC Nephrol; 2004 Oct 05; 5():12. PubMed ID: 15462683
    [Abstract] [Full Text] [Related]

  • 36. Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease - a call for caution.
    Onuigbo MA.
    Nephron Clin Pract; 2009 Oct 05; 113(2):c63-9, discussion c70. PubMed ID: 19602900
    [Abstract] [Full Text] [Related]

  • 37. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E.
    Am Heart J; 2009 Jun 05; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [Abstract] [Full Text] [Related]

  • 38. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K.
    Am J Hypertens; 2007 Nov 05; 20(11):1195-201. PubMed ID: 17954367
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets.
    Thanamayooran S, Rose C, Hirsch DJ.
    Nephrol Dial Transplant; 2005 Nov 05; 20(11):2385-93. PubMed ID: 16046506
    [Abstract] [Full Text] [Related]

  • 40. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
    Imai E, Takenaka M, Isaka Y, Moriyama T, Akagi Y, Kakuchi J, Fujii T, Ito T, Hori M, Horio M, Syoji T, Tsubakihara Y.
    Clin Exp Nephrol; 2003 Jun 05; 7(2):113-9. PubMed ID: 14586729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.